Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine. Afferi L, Spahn M, Hayoz S, Strebel RT, et al. BJU Int 2024;134:388-397.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Afferi L, Spahn M, Hayoz S, Strebel RT, et al. Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine. BJU Int 2024;134:388-397.
PMID: 38456541